304 filings
Page 4 of 16
4
ujr3k jtrxncg08vzq
15 Feb 19
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:31pm
SC 13G/A
au0434kyyhuu1
14 Feb 19
GW Pharmaceuticals PLC
3:24pm
SC 13G/A
p0p3nr71j
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
ak0dblxhuwwafi3
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
prujqe c2
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G
z4khdd av644jcy
14 Feb 19
GW Pharmaceuticals PLC
12:00am
S-3ASR
rwejibkfof0mrqyf69
18 Jan 19
Automatic shelf registration
5:01pm
8-K
w158a6i4xhvj6 7e
7 Jan 19
Regulation FD Disclosure
6:13am
4
tn2 wnnhtkep
4 Jan 19
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:15pm
4
t6yekxozp755f
26 Dec 18
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:15pm
10-K
mfwphi nk0q
28 Nov 18
Annual report
8:58pm
8-K
w6t5ynno y8z65
27 Nov 18
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
4:05pm
8-K
z64b8q
26 Nov 18
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
4:15pm
4
nl12fqgw956s
23 Nov 18
GW PHARMACEUTICALS / Adam D. George ownership change
4:30pm
8-K
abfgyzc
5 Oct 18
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs
5:08pm
424B5
asiy4psbxj9t
3 Oct 18
Prospectus supplement for primary offering
5:30pm
8-K
zke0w0vw6wbhd5
1 Oct 18
Other Events
4:14pm
424B5
jyzbj76yqu2
1 Oct 18
Prospectus supplement for primary offering
4:12pm
3
9jhzfv3nr2k67 5wknc
1 Oct 18
GW PHARMACEUTICALS / William A. Waldegrave ownership change
12:00am
3
tao0z7a984ng
1 Oct 18
GW PHARMACEUTICALS / Julian S Gangolli ownership change
12:00am